PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-22.22%
Negative net income growth while CRK stands at 49.29%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
10.34%
D&A growth well above CRK's 13.44%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-173.24%
Negative yoy deferred tax while CRK stands at 8.41%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
74.47%
Slight usage while CRK is negative at -246.23%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
74.47%
Growth of 74.47% while CRK is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
123.72%
Lower 'other non-cash' growth vs. CRK's 1804.96%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
12.92%
Some CFO growth while CRK is negative at -12.80%. John Neff would note a short-term liquidity lead over the competitor.
-19.75%
Both yoy lines negative, with CRK at -7.04%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-65.00%
Both yoy lines negative, with CRK at -100.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-105.59%
Both yoy lines negative, with CRK at -7.19%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
32.90%
Debt repayment growth of 32.90% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
95.48%
We slightly raise equity while CRK is negative at -99.02%. John Neff sees competitor possibly preserving share count or buying back shares.
12.03%
Buyback growth of 12.03% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.